Nurse Practitioner · Oak Ridge, TN
NPI
1689637340
Since 2006
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
800 Oak Ridge Turnpike, Suite A-402
Oak Ridge, TN, 37830
Phone (865) 637-8812
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
2,034 services
Medicare patients, 2024
187
Average age 71
Drug cost, 2024
$3.6M
4,763 prescriptions
Company payments, 2025
$378
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael B Wiseman was code 99214 (office e&m - established), 366 times for 173 patients. In total Michael B Wiseman billed 2,034 services in 35 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-03-31.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 366 | 173 | $69.85 | $26K |
| 83036 Blood Count | Office | 358 | 174 | $9.25 | $3,313 |
| 84443 Clinical Chemistry | Office | 175 | 131 | $16.41 | $2,872 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 159 | 116 | $10.20 | $1,623 |
| 80061 Clinical Chemistry | Office | 159 | 131 | $13.11 | $2,085 |
| 36415 Venipuncture Blood Collection | Office | 155 | 122 | $8.59 | $1,332 |
| 80053 Clinical Chemistry | Office | 153 | 125 | $10.32 | $1,579 |
| 82570 Clinical Chemistry | Office | 146 | 120 | $5.07 | $741 |
| 82043 Clinical Chemistry | Office | 146 | 120 | $5.66 | $826 |
| 99213 Office E&M - Established | Office | 51 | 46 | $36.18 | $1,845 |
| 99205 Office E&M - New | Office | 20 | 20 | $107.29 | $2,146 |
| 82607 Clinical Chemistry | Office | 17 | 17 | $14.78 | $251 |
| 82306 Clinical Chemistry | Office | 14 | 14 | $29.01 | $406 |
By year: 2022 $40K for 1,870 services; 2023 $41K for 1,659 services; 2024 $47K for 2,034 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 358 | 174 | $9.25 | $3,313 |
| 84443 Clinical Chemistry | 175 | 131 | $16.41 | $2,872 |
| 80061 Clinical Chemistry | 159 | 131 | $13.11 | $2,085 |
| 36415 Venipuncture Blood Collection | 155 | 122 | $8.59 | $1,332 |
| 80053 Clinical Chemistry | 153 | 125 | $10.32 | $1,579 |
| 82570 Clinical Chemistry | 146 | 120 | $5.07 | $741 |
| 82043 Clinical Chemistry | 146 | 120 | $5.66 | $826 |
| 82607 Clinical Chemistry | 17 | 17 | $14.78 | $251 |
| 82306 Clinical Chemistry | 14 | 14 | $29.01 | $406 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael B Wiseman prescribed most often to Medicare patients was Ozempic (Semaglutide), with 399 prescriptions and refills. In total Michael B Wiseman wrote 4,763 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 399 | 617 | 78 | $580K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 398 | 615 | 90 | $457K |
| Tresiba Flextouch U-200 Insulin Degludec | 300 | 460 | 66 | $354K |
| Synjardy Xr Empagliflozin/Metformin Hcl | 230 | 430 | 46 | $236K |
| Novolog Flexpen Insulin Aspart | 206 | 300 | 74 | $44K |
| Mounjaro Tirzepatide | 189 | 248 | 34 | $252K |
| Levothyroxine Sodium Generic | 182 | 449 | 47 | $1,555 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 158 | 231 | 38 | $98K |
| Jardiance Empagliflozin | 156 | 291 | 31 | $159K |
| Novolog Insulin Aspart | 109 | 167 | 22 | $31K |
| Fiasp Flextouch Insulin Aspart (Niacinamide) | 108 | 162 | 37 | $84K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 102 | 221 | 43 | $11K |
| Glimepiride Generic | 97 | 239 | 26 | $664 |
| Omnipod Dash Pods (Gen 4) Insulin Pump Cart,cont Inf,bt | 95 | 107 | 15 | $72K |
| Trulicity Dulaglutide | 94 | 144 | 23 | $137K |
Brand drugs: 3,458 claims; generic drugs: 686 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael B Wiseman $378 ($378 in general payments such as food, travel and fees) from 11 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $121.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $121 |
| Dexcom, Inc. DXCM | 1 | $50.01 |
| Abbott Laboratories ABT | 2 | $35.91 |
| Novo Nordisk Inc NVO | 1 | $26.38 |
| Mannkind Corporation MNKD | 1 | $24.19 |
| Tandem Diabetes Care, Inc. TNDM | 1 | $23.6 |
| CeQur Corporation | 1 | $21.77 |
| Amphastar Pharmaceuticals, Inc. AMPH | 1 | $19.68 |
| Pfizer Inc. PFE | 1 | $19.35 |
| Xeris Pharmaceuticals, Inc. | 1 | $18.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.